Despite strict controls, some infants born to mothers with COVID-19 appear infectedMarch 27, 2020Pediatrics
Perspective from the heartland: Cancer care and research during a public health crisisMarch 26, 2020Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Disruptions in cancer care in the era of COVID-19March 20, 2020Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
COVID-19: U.S. cardiology groups reaffirm continued use of RAAS-active drugsMarch 18, 2020Related Issues
FDA approves new drug for relapsed/refractory multiple myelomaMarch 2, 2020Multiple MyelomaLymphoma & Plasma Cell Disorders
Late effects in young cancer survivors underscore importance of high-risk screeningFebruary 21, 2020Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatrics
Phase 2 data: Inotuzumab, approved in adults with B-ALL, shows promise in kids, tooFebruary 11, 2020ALLLeukemia, Myelodysplasia, Transplantation
FDA: Cell phones still look safeFebruary 11, 2020Lymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, Transplantation
CRISPR-engineered T cells may be safe for cancer, but do they work?February 6, 2020Multiple MyelomaLymphoma & Plasma Cell Disorders
Global project reveals cancer’s genomic playbookFebruary 5, 2020Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
